News Releases

Oct 28, 2020
Lyra Therapeutics Appoints Nancy L. Snyderman To Its Board of Directors
WATERTOWN, Mass. --(BUSINESS WIRE)--Oct. 28, 2020-- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat (ENT)
Additional Formats
Displaying 1 - 10 of 19
Print Page
Email Alerts
RSS Feeds
Contact IR
Search
Back to Top